FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Streilein, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Streilein, J. W.

The FASEB Journal, Vol 1, 199-208, Copyright © 1987 by The Federation of American Societies for Experimental Biology

REVIEWS

Immune regulation and the eye: a dangerous compromise

JW Streilein

The thesis is advanced that immune responses to intraocular antigens are unique and highly specialized. Anterior chamber-associated immune deviation (ACAID) is the term used to identify this specialized response, which consists of selectively impaired immunity of the delayed hypersensitivity (DH) type coexistent with intact humoral immunity and priming of cytotoxic T cell activity. Induction of T cell suppression, which is partly responsible for ACAID, interferes with expression of DH within the eye as well as systemically. It is proposed that the ability of the eye to make a compromise with the immune system and thereby arrange for the selective suppression of delayed hypersensitivity results from the need to avoid intraocular inflammatory reactions that are intense and productive of nonspecific "innocent bystander" injury. When reactions of this type occur within the eye, the visual axis is disrupted, and vision is destroyed. However, avoidance of DH may have deleterious consequences both for the eye and for the host. The impact of ACAID is discussed with regard to the distinctive patterns of ocular disease produced experimentally in mice by melanoma cells and by herpes simplex virus type 1.


This article has been cited by other articles:


Home page
 IOVSHome page
J. E. Knickelbein, S. Divito, and R. L. Hendricks
Modulation of CD8+ CTL Effector Function by Fibroblasts Derived from the Immunoprivileged Cornea
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2194 - 2202.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Hori, M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
J. Immunol., November 1, 2006; 177(9): 5928 - 5935.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Keino, S. Masli, S. Sasaki, J. W. Streilein, and J. Stein-Streilein
CD8+ T Regulatory Cells Use a Novel Genetic Program that Includes CD103 to Suppress Th1 Immunity in Eye-Derived Tolerance.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1533 - 1542.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Keino, M. Takeuchi, T. Kezuka, T. Hattori, M. Usui, O. Taguchi, J. W. Streilein, and J. Stein-Streilein
Induction of Eye-Derived Tolerance Does Not Depend on Naturally Occurring CD4+CD25+ T Regulatory Cells.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1047 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Verma, S. Artiushin, J. Matsunaga, D. A. Haake, and J. F. Timoney
LruA and LruB, Novel Lipoproteins of Pathogenic Leptospira interrogans Associated with Equine Recurrent Uveitis
Infect. Immun., November 1, 2005; 73(11): 7259 - 7266.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Takeuchi, H. Keino, T. Kezuka, M. Usui, and O. Taguchi
Immune Responses to Retinal Self-Antigens in CD25+CD4+ Regulatory T-Cell-Depleted Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1879 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. W. Streilein
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
J. Leukoc. Biol., August 1, 2003; 74(2): 179 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
R. E. Cone, G. M. Georgiou, and C. H. Little
Soluble T-Lymphocyte Antigen-Specific Immunoproteins: A Progress Report
Experimental Biology and Medicine, July 1, 2002; 227(7): 438 - 444.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Katagiri, J. Zhang-Hoover, J. S. Mo, J. Stein-Streilein, and J. W. Streilein
Using Tolerance Induced Via the Anterior Chamber of the Eye to Inhibit Th2-Dependent Pulmonary Pathology
J. Immunol., July 1, 2002; 169(1): 84 - 89.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Ruan, J. Chodosh, M. C. Callegan, M. C. Booth, T. D. Lee, P. Kumar, M. S. Gilmore, and H. A. Pereira
Corneal Expression of the Inflammatory Mediator CAP37
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1414 - 1421.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-H. Sonoda, M. Taniguchi, and J. Stein-Streilein
Long-Term Survival of Corneal Allografts Is Dependent on Intact CD1d-Reactive NKT Cells
J. Immunol., February 15, 2002; 168(4): 2028 - 2034.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
T. Kezuka, J.-i. Sakai, N. Usui, J. W. Streilein, and M. Usui
Evidence for Antigen-Specific Immune Deviation in Patients With Acute Retinal Necrosis
Arch Ophthalmol, July 1, 2001; 119(7): 1044 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. Wang, I. Goldschneider, J. O’Rourke, and R. E. Cone
Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation
J. Leukoc. Biol., May 1, 2001; 69(5): 741 - 746.
[Abstract] [Full Text]

Home page
 IOVSHome page
J. Yamada, B. R. Ksander, and J. W. Streilein
Cytotoxic T Cells Play No Essential Role in Acute Rejection of Orthotopic Corneal Allografts in Mice
Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 386 - 392.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
K.-H. Sonoda, D. E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein
NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance
J. Immunol., January 1, 2001; 166(1): 42 - 50.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Hori, N. C. Joyce, and J. W. Streilein
Immune Privilege and Immunogenicity Reside among Different Layers of the Mouse Cornea
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3032 - 3042.
[Abstract] [Full Text]

Home page
 IOVSHome page
T. Kezuka and J. W. Streilein
In Vitro Generation of Regulatory CD8+ T Cells Similar to those Found in Mice with Anterior Chamber-Associated Immune Deviation
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1803 - 1811.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
H. Wenkel, J. W. Streilein, and M. J. Young
Systemic Immune Deviation in the Brain That Does Not Depend on the Integrity of the Blood-Brain Barrier
J. Immunol., May 15, 2000; 164(10): 5125 - 5131.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Kezuka and J. W. Streilein
Analysis of In Vivo Regulatory Properties of T Cells Activated In Vitro by TGF{beta}2-Treated Antigen Presenting Cells
Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1410 - 1421.
[Abstract] [Full Text]

Home page
 IOVSHome page
Y. Sano, B. R. Ksander, and J. W. Streilein
Langerhans Cells, Orthotopic Corneal Allografts, and Direct and Indirect Pathways of T-Cell Allorecognition
Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1422 - 1431.
[Abstract] [Full Text]

Home page
 IOVSHome page
A. Sonoda, Y. Sonoda, R. Muramatu, J. W. Streilein, and M. Usui
ACAID Induced by Allogeneic Corneal Tissue Promotes Subsequent Survival of Orthotopic Corneal Grafts
Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 790 - 798.
[Abstract] [Full Text]

Home page
 IOVSHome page
M. Yoshida, M. Takeuchi, and W. Streilein
Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact
Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 811 - 821.
[Abstract] [Full Text]

Home page
 IOVSHome page
J. Hori, N. Joyce, and J. W. Streilein
Epithelium-Deficient Corneal Allografts Display Immune Privilege beneath the Kidney Capsule
Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 443 - 452.
[Abstract] [Full Text]

Home page
 IOVSHome page
H. Wenkel, P. W. Chen, B. R. Ksander, and J. W. Streilein
Immune Privilege Is Extended, then Withdrawn, from Allogeneic Tumor Cell Grafts Placed in the Subretinal Space
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3202 - 3208.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K.-H. Sonoda, M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein
CD1-reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site
J. Exp. Med., November 1, 1999; 190(9): 1215 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. R. H. M. Schurmans, A. Th. den Boer, L. Diehl, E. I. H. van der Voort, W. M. Kast, C. J. M. Melief, R. E. M. Toes, and M. J. Jager
Successful Immunotherapy of an Intraocular Tumor in Mice
Cancer Res., October 1, 1999; 59(20): 5250 - 5254.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. Miller, J. A. Ragheb, and R. H. Schwartz
Anergy and Cytokine-mediated Suppression as Distinct Superantigen-induced Tolerance Mechanisms In Vivo
J. Exp. Med., July 5, 1999; 190(1): 53 - 64.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Yamada, M. Yoshida, A. W. Taylor, and J. W. Streilein
Mice with Th2-Biased Immune Systems Accept Orthotopic Corneal Allografts Placed in "High Risk" Eyes
J. Immunol., May 1, 1999; 162(9): 5247 - 5255.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Kosiewicz, P. Alard, and J. W. Streilein
Alterations in Cytokine Production Following Intraocular Injection of Soluble Protein Antigen: Impairment in IFN-{gamma} and Induction of TGF-{beta} and IL-4 Production
J. Immunol., November 15, 1998; 161(10): 5382 - 5390.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
J. Yamada, M. R. Dana, S.-N. Zhu, P. Alard, and J. W. Streilein
Interleukin 1 Receptor Antagonist Suppresses Allosensitization in Corneal Transplantation
Arch Ophthalmol, October 1, 1998; 116(10): 1351 - 1357.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. C. Buenafe, H. Offner, M. Machnicki, H. Elerding, K. Adlard, R. Jacobs, A. A. Vandenbark, and G. Adamus
EAE TCR Motifs and Antigen Recognition in Myelin Basic Protein-Induced Anterior Uveitis in Lewis Rats
J. Immunol., August 15, 1998; 161(4): 2052 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Takeuchi, P. Alard, and J. W. Streilein
TGF-{beta} Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells
J. Immunol., February 15, 1998; 160(4): 1589 - 1597.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by The Federation of American Societies for Experimental Biology.